Inheritance of Osteosarcoma & Paget's Disease Through Chromosome 18:
- Status
- TERMINATED
- Phase
- N/A
Clinical Trials Related to Osteosarcoma
Related studies linked through entity extraction aliases.
Huntsman Biopsy Study
- Status
- TERMINATED
- Phase
- N/A
Detection of Circulating Osteosarcoma Tumor Cells in the Blood of Patients Using the Polymerase Chain Reaction
- Status
- COMPLETED
- Phase
- N/A
Phase II Study of Chemotherapy and Pamidronate for the Treatment of Newly Diagnosed Osteosarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy Resistance in Osteogenic Sarcoma and Other Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Phase II Study of Intravenous Rexin-G in Osteosarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy for Patients With Osteosarcoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Pemetrexed in Children With Recurrent Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung
- Status
- COMPLETED
- Phase
- PHASE2
HGS-ETR2 to Treat Children With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Orthopaedic Data Bank (Acute and Chronic)
- Status
- RECRUITING
- Phase
- N/A
Clinical Studies of Gemcitabine-Oxaliplatin
- Status
- COMPLETED
- Phase
- PHASE2
Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Comparison of High-Dose Methotrexate (HDM) Plus Doxorubicin to HDM Plus Etoposide-Ifosfamide in Osteosarcoma Children
- Status
- COMPLETED
- Phase
- PHASE3
Osteosarcoma1999-A Study Of Intensive Chemotherapy for Osteosarcoma
- Status
- COMPLETED
- Phase
- PHASE2
ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE2
Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Eligibility Screening for a NCI Pediatric Oncology Branch Research Study
- Status
- COMPLETED
- Phase
- N/A